Filing Details

Accession Number:
0001179110-12-004962
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-13 18:56:04
Reporting Period:
2012-03-09
Filing Date:
2012-03-13
Accepted Time:
2012-03-13 18:56:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
916085 Health Net Inc HNT Hospital & Medical Service Plans (6324) 954288333
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197666 B Vicki Escarra C/O Health Net, Inc.
21650 Oxnard Street
Woodland Hills CA 91367
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-09 7,367 $15.30 14,713 No 4 M Direct
Common Stock Disposition 2012-03-09 4,916 $39.34 9,797 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2012-03-09 7,367 $0.00 7,367 $15.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,366 2010-05-22 2016-05-22 No 4 M Direct
Footnotes
  1. Exercise of a stock option granted to the Reporting Person on May 22, 2009, under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "Grant"), in a transaction exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended.
  2. The Grant became exercisable with respect to 33-1/3% of the options on each of the first and second anniversary of the grant date of May 22, 2009, respectively, and will become exercisable with respect to the remaining 33-1/3% of the options on the third anniversary of the grant date.
  3. Represents unvested and unexercised options from the Grant benefically owned by the Reporting Person.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.28 to $39.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.